RxDoctor Payments Data

Rylee Runnels

Family · Layton, UTNPI 1578342069

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.5% of the total across 161 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 24 manufacturers reported payments, led by Sanofi at 30.3% of the total.

$2,958in general payments, 2019–2025

Across 161 payments — averaging $18.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi$897
  • AstraZeneca$372
  • Takeda Pharmaceuticals U.S.A., Inc.$304
  • Regeneron Healthcare Solutions, Inc.$197
  • Grifols USA, LLC$191
  • Novartis$172
  • plus $825 from 18 others

What the payments were for

  • Consulting fees$452%
  • Food & beverage$2,91398%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,958 in reported general payments places this provider in the 85th percentile of 1,460 family providers in Utah.

See all family providers in Utah →

Other family in Layton

See the full list for Utah →

Where these figures come from

Is this you, or does something look wrong? →